Table 7.

Comparison of results obtained by qPCR and by dPCR to investigate ABL1 mutations.

T315I
Patient ID	Sample ID	qPCR	dPCR	%BCR::ABL1 (IS)	Treatment
Patient 1	Sample 1	WT	WT	0.054	Nilotinib
	Sample 2	T315I	T315I	100
Patient 2	Sample 1	WT	WT	22.92	BMT
	Sample 2	WT	T315I	NA
Patient 3	Sample 1	WT	T315I	0.281	BMT
Patient 4	Sample 1	WT	T315I	0.315	Dasatinib
Patient 5	Sample 1	WT	T315I	8.9	Dasatinib
Patient 6	Sample 1	WT	T315I	1,38	Imatinib
E255K
Patient ID	Sample ID	qPCR	dPCR	%BCR::ABL1 (IS)	Treatment
Patient 7	Sample 1	WT	WT	61.12	Imatinib
	Sample 2	WT	E255K	72.7
	Sample 3	E255K	E255K	80.6
	Sample 4	WT	WT	8.19	Dasatinib
V359F
Patient ID	Sample ID	qPCR	dPCR	%BCR::ABL1 (IS)	treatment
Patient 8	Sample 1	WT	WT	47.3	None
	Sample 2	V359F	V359F	43.2	Nilotinib

Wt represents “wild-type”; BMT “Bone marrow transplantation”; and NA “Not available”.